A former part-time JCPenney employee has filed a lawsuit claiming retaliation after he reported the retailer was overcharging customers.
The fired employee has filed a claim against the company under Florida’s Private Whistleblower Act, Fortune reports. Former CEO Ron Johnson could be required to give a deposition. Continue reading
Medical device maker Zimmer, Inc. has initiated a voluntary recall of nearly 12,000 Persona Trabecular Metal Tibial knee replacement devices in response to increased complaints of loosening of the device.
The recall covers the Persona Trabecular Metal Tibial Plate/Persona TM Tibia-Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer, all lots land sizes, left and right. Research has shown that radiolucent lines (seen on x-rays), which show the gap between the cement and the device component, can be associated with early failure of the device. Some recipients have needed revision surgery to replace the defective component. Continue reading
Data from the U.S. Food and Drug Administration (FDA) shows that there are over 100,000 medical devices on the market. Unfortunately, not all of them are safe. In fact, agency data indicates that between 13 and 75 devices are recalled in the United States every day. Motley Fool reports that a regulatory loophole, which allows devices to be sold and implanted into patients without clinical testing, may be a major contributing factor to these statistics.
Manufacturers can submit certain devices for 510(k) approval; this process can allow a device to be sold on the market without clinical testing for safety or efficacy so long as the FDA finds that the product is “substantially equivalent” to an older product. Only Class I and Class II devices are eligible for 510(k) clearance. Class III “high-risk” devices must go through the more stringent premarket approval. Continue reading
A recent court order has directed the parties to select seven cases that may be included in the second Mirena intrauterine device (IUD) trial.
According to a court order filed on March 17, 2015, each side must select seven cases for potential inclusion in the Second Disposition Pool. The case is In Re: Mirena Litigation, Case No. 297 in the Superior Court of New Jersey Law Division: Bergen County. Raymond C. Silverman, partner at Parker Waichman LLP, has been appointed co-lead counsel in the litigation. Continue reading
Antipsychotic medications are sometimes used to treat aggressive or violent behavior in patients with dementia, but new research suggests that health care professionals should consider the risks closely before prescribing them. According to study published in JAMA Psychiatry, antipsychotic medications can increase the risk of early death in patients with dementia, including those with Alzheimer’s Disease. The U.S. Food and Drug Administration (FDA) already warns that antipsychotic drugs can have serious side effects in patients with dementia. The findings from this study support the practice of not using these drugs in dementia patients.
Using medical records from over 91,000 veterans over the age of 65, researchers from the University of Michigan’s Medical School and VA Center for Clinical Management Research compared mortality death rates between patients taking antipsychotic drugs for dementia to those who did not. The study found a 3.8 percent increased risk of death in patients taking haloperidol compared to those who did not take any antipsychotic medications. There was a 2.5 percent increased risk of death in patients taking olanzapine. Continue reading
The New York Times reports that Biomet’s federal probation was set to expire next week, but new evidence of foreign bribery has extended it by a year. During that time, the Justice Department will investigate the issue.
Additionally, the Justice Department will be looking into whether Biomet was involved in the bribery of government officials in Mexico and Brazil. The company settled a bribery case in 2012 for $17 million, according to NYT. Biomet also entered into a so-called deferred prosecution that withholds criminal charges if the company does not commit any wrongdoing during three years of probation. Continue reading
While clinical trial results for AstraZeneca’s heart drug Brilinta (ticagrelor) are positive, the trail showed bleeding risks with the blood-thinning drug.
A 21,000-patient clinical trial showed Brilinta (ticagrelor) cuts heart attacks and strokes, but caused more bleeding, Reuters reports. Continue reading
A retired police officer has successfully won an appeal for disability pension after years of legal struggle. The Chief reports that last month, a state appeals court ruled in her favor. The offer serviced over 300 hours at Ground Zero and developed fibromyalgia, among other conditions. She is represented by Jeffrey Goldberg, an attorney with the national law firm of Parker Waichman LLP.
The officer was a first responder on September 11th.Court records show that she was assigned to a security post a block away from Ground Zero in October 2001. After developing shortness of breath, dizziness, nausea and severe chest pains, she was diagnosed with fibromyalgia in March 2002. According to court documents, she filed for disability retirement in 2008 but was denied. The medical board of the Police Pension Fund acknowledged that her fibromyalgia and chronic fatigue syndrome left her unable to work, but asserted that these conditions were not caused by 9/11. She was denied again when reapplying several months later. The officer challenged these decisions by filing an Article 78 petition in State Supreme Court, but did not win. Continue reading